Notably, the CD4/CD8 ratio, which was reported as an immune biomarker, also showed no significant difference (pneumonia vs stable, 1.21 ± 0.61 vs 1.12 ± 0.59, P = 0.320). Here, CD8A is linked to susceptibility to pneumonia measurement.